ArticlePloS one2016

Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis.

Rolf Billeskov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.